{"id":14601,"date":"2012-02-17T19:30:00","date_gmt":"2012-02-17T18:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/appello-dei-lavoratori-e-ex-lavoratori-sigma-tau-ai-media\/"},"modified":"2012-02-17T19:30:00","modified_gmt":"2012-02-17T18:30:00","slug":"appello-dei-lavoratori-e-ex-lavoratori-sigma-tau-ai-media","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/appello-dei-lavoratori-e-ex-lavoratori-sigma-tau-ai-media\/","title":{"rendered":"Appeal by Sigma Tau workers and former workers to the media."},"content":{"rendered":"

Hereby, the workers and ex-workers of Sigma-tau - united pharmaceutical industries - are asking RAI, the state television, and national television to report on their newscasts what is happening in the company.<\/p>\n

<\/font><\/font><\/p>\n

In particular, we are referring to the decision of the Sigma-tau company to lay off 569 workers at zero hours, a decision that goes hand in hand with that of shifting its economic interest to America and its earnings to tax havens such as Madeira in Portugal.<\/p>\n

<\/font><\/font><\/p>\n

Sigma-tau, which in the past has benefited from state money (from subsidized cash registers for midday, to aid for the introduction of new personnel through scholarships paid by MURST, just to name a few), in fact bought Enzon pharmaceutical, an American giant listed on the Nasdaq, for 301 million dollars in 2010. And it is precisely the purchase of ENZON that will guarantee, according to the financial statements, a turnover of 130 million dollars, most of which, however, will not end up in the coffers of Sigma-tau, but of the subsidiary Defiante based in Portugal.<\/p>\n

<\/font><\/font><\/p>\n

 <\/span>And it is thanks to these economic maneuvers that Sigma-tau declares a state of crisis in its Italian offices and puts two associates, Prassis of Milan and Tecnogen of Caserta, into liquidation.<\/p>\n

<\/font><\/font><\/p>\n

 <\/span>At the Pomezia site, for which the company declares a loss of 20 million euros for 2010, 400 letters of extraordinary redundancy leave on 18 January.<\/p>\n

<\/font><\/font><\/p>\n

 <\/span>Sigma-tau is a leading company in the pharmaceutical sector, worldwide, one of the few that our country still has. It is a company that has had moments of great innovation in the pharmaceutical field and therefore constitutes a heritage of our country which it would be terrible to squander.<\/p>\n

<\/font><\/font><\/p>\n

 <\/span>Although the Lazio Region has been very active on this matter and 7 parliamentary questions have been made to date (see below), Sigma-tau continues to evade any type of constructive confrontation by cutting sectors such as research and sales promotion (pharmaceutical sales representatives) and, therefore, reasonably cutting any prospect of investment in Italy.<\/p>\n

<\/font><\/font><\/p>\n

 <\/span>In this way, the company also fails to fulfill its SOCIAL RESPONSIBILITY towards those workers who have made life choices and who have trusted the company.<\/p>\n

<\/font><\/font><\/p>\n

 <\/span>Many of these workers are between the ages of 30 and 40 and many of these, after a period of precariousness, had imagined they were in a strong m<\/p>","protected":false},"excerpt":{"rendered":"

Con la presente, i lavoratori ed ex-lavoratori della Sigma-tau – industrie farmaceutiche riunite – chiedono alla RAI, televisione di stato, e alle televisioni nazionali di dare notizia nei loro telegiornali di quanto sta accadendo nell’azienda. In particolare, ci riferiamo alla decisione della società Sigma-tau di mettere in cassa integrazione straordinaria a zero ore 569 lavoratori, …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14601"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14601\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}